Selway Asset Management Amgen Inc Transaction History

Selway Asset Management

$254 Million
Q3 2024

A detailed history of Selway Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Selway Asset Management holds 14,267 shares of AMGN stock, worth $3.76 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares

14,267

Previous 14,217 0.35%

Holding current value

$3.76 Million

Previous $4.44 Million 3.47%

% of portfolio

1.81%

Previous 1.82%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$309.38 - $337.38 $15,469 - $16,869	50 Added 0.35%	14,267 $4.6 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $15,765 - $19,158	60 Added 0.42%	14,217 $4.44 Million
Q1 2024 Apr 10, 2024	BUY	$268.87 - $324.56 $3.33 Million - $4.02 Million	12,400 Added 705.75%	14,157 $4.03 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $449,264 - $506,824	1,757 New	1,757 $506,000
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $15,742 - $19,545	72 New	72 $19,000
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $11,223 - $12,657	50 New	50 $11,000
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $273,113 - $307,858	-1,510 Closed	0 $0
Q2 2018 Jul 24, 2018	SELL	$166.05 - $186.51 $33,210 - $37,302	-200 Reduced 11.7%	1,510 $279,000
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $152,487 - $178,200	-900 Reduced 34.48%	1,710 $292,000
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $50,637 - $56,577	-300 Reduced 10.31%	2,610 $454,000
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $486,813 - $555,810	2,910	2,910 $543,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Selway Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Selway Asset Management with notifications on news.

Account

Selway Asset Management Amgen Inc Transaction History